NCT06034197View on ClinicalTrials.gov

Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Colorectal Cancer

Interventions

DRUG

VGT-309

0.32mg/kg IV of VGT-309 given 12-36 hours before surgery

Trial Locations (1)

94304

RECRUITING

Stanford University, Palo Alto

All Listed Sponsors

lead

Stephan Rogalla

OTHER